Streetbeat News

Earnings

NCLH

Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) reported a 30.8% year-on-year sales growth for Q4 fiscal 2023, with revenues of $1.986 billion slightly above consensus. Adjusted EPS improved but missed expectations. The company saw a significant recovery compared to 2019, with total revenue and per Passenger Cruise Day up by 34% and 21%, respectively. Operating income turned positive, and adjusted EBITDA significantly improved. The company provided a strong outlook for 2024, expecting an Adjusted EPS of ~$1.23 and Adjusted EBITDA of ~$2.2 billion. Shares surged 17.5% to $18.72.

Portfolio Pulse from Akanksha Bakshi

February 27, 2024 | 4:12 pm

STRL

Sterling Infrastructure's shares surged following the announcement of its Q4 financial results, which exceeded expectations. Additionally, the company provided an optimistic adjusted EPS guidance for FY24, surpassing analysts' forecasts.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 4:10 pm

DNLI

Denali Therapeutics announced a $500 million private placement equity financing and reported its Q4 financial results, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 4:03 pm

SBOW

SilverBow Resources (NYSE:SBOW) is anticipated to report an EPS of $2.19 in its upcoming quarterly earnings on 2024-02-28. Analysts and investors are keen on whether SBOW will surpass this estimate and provide positive future guidance. Historically, SBOW has shown a pattern of beating EPS estimates, leading to significant share price movements. The stock, currently trading at $27.64, has seen an 11.08% increase over the last 52 weeks, indicating a positive trend for long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:02 pm

TALO

Talos Energy (NYSE:TALO) is scheduled to release its quarterly earnings report on February 28, 2024, with analysts expecting an EPS of $0.17. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 4.17% drop. Shares are currently trading at $12.96, down 17.28% over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:02 pm

IMCR

Immunocore Hldgs (NASDAQ:IMCR) is scheduled to release its quarterly earnings report on February 28, 2024, with analysts expecting an EPS of $-0.28. The company's past performance shows a mixed record of beating EPS estimates, with a notable beat last quarter resulting in a 2.45% share price increase the following day. Shares are currently trading at $70.97, reflecting a 30.01% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:02 pm

PAGS

PagSeguro Digital (NYSE:PAGS) is anticipated to release its quarterly earnings report on February 28, 2024, with an expected EPS of $0.30. Historical data shows a positive correlation between earnings performance and stock price movement. Last quarter, PAGS exceeded EPS estimates, resulting in a 4.86% stock price increase. Over the past year, PAGS shares have risen by 59.52%, indicating a bullish outlook among long-term investors.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:01 pm

STN

Stantec (NYSE:STN) is scheduled to release its quarterly earnings report on February 28, 2024, with analysts expecting an EPS of $0.64. The company's past performance shows a pattern of beating EPS estimates, leading to significant share price movements. Shares of Stantec have increased by 44.82% over the last 52 weeks, indicating a positive outlook from long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:01 pm

STN

Stantec (NYSE:STN) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.64. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Stantec's past earnings performance shows a pattern of beating EPS estimates, leading to significant share price movements. The company's stock has seen a 44.82% increase over the last 52 weeks, indicating a positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:01 pm

TGTX

TG Therapeutics (NASDAQ:TGTX) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $-0.10. The company's past performance shows a history of beating EPS estimates, which has positively impacted its share price in the short term. However, over the last 52 weeks, TGTX shares have declined by 8.88%, indicating potential concerns among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 4:01 pm